dcvac/ovca in parallel
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2013 (NCT02107950)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dcvac/ovca in parallel
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02107378 | Phase 2 | Jan 1, 2014 | Accord Research |
| NCT02107937 | Phase 2 | Nov 1, 2013 | Accord Research |
| NCT02107950 | Phase 2 | Nov 1, 2013 | Accord Research |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Accord Research | For profit | 3 | 3 | 1 | 2013 |
1 organizations
Page 1 / 1